A Mechanistic Study to Assess Whether Isoproterenol Can Reverse the Negative Chronotropic Effect of Fingolimod
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
2006 • 1,043 citations
Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology
2007 • 524 citations
Signaling and biological actions of sphingosine 1-phosphate
2003 • 272 citations
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity
2002 • 265 citations
Molecular and Cellular Diversity of Neuronal G-Protein-Gated Potassium Channels
2005 • 198 citations
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P 3
2005 • 122 citations
FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects
2006 • 111 citations
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
2007 • 93 citations
Single‐dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects
2004 • 80 citations
Handbook of emergency cardiovascular care for healthcare providers
2006 • 72 citations
Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells
1999 • 70 citations
Ethnic sensitivity study of fingolimod in white and Asian subjects
2007 • 24 citations
FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment
2005 • 18 citations
Cited By (0)
No citing papers found in database